Clinical inquiries. In patients with a previous CVA, do antioxidants protect against subsequent stroke?
Spencer
Donald C
DC
University of North Carolina at Chapel Hill, Dept of Family Medicine, USA.
Meadows
Susan E
SE
Sontheimer
Dan
D
D000368:Aged; D000975:Antioxidants / Q000008:administration & dosage*; D016001:Confidence Intervals; D019587:Dietary Supplements; D019317:Evidence-Based Medicine; D005260:Female; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D016032:Randomized Controlled Trials as Topic; D012016:Reference Values; D012307:Risk Factors; D055502:Secondary Prevention; D012720:Severity of Illness Index; D012907:Smoking / Q000009:adverse effects; D020521:Stroke / Q000188:drug therapy* / Q000453:epidemiology / Q000517:prevention & control*; D016019:Survival Analysis; D016896:Treatment Outcome; D014810:Vitamin E / Q000008:administration & dosage*
D000975:Antioxidants; D014810:Vitamin E